Back
Bicara Therapeutics Vs. TD Synnex Industry Stock Comparison
Buy
59
BCAX
Bicara Therapeutics
Last Price:
$13.10
Seasonality Move:
--
Sell
18
SNX
TD Synnex
Last Price:
$103.94
Seasonality Move:
5.15%
Buy
59
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.03. The Score for BCAX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight selling pressure.
SNX Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 47.37 | Sell |
Chaikin Money Flow: | -130382 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.36 - 14.42) | Sell |
Bollinger Bands (100): | (12.28 - 19.98) | Sell |
SNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.5 | Sell |
Relative Strength Index (14 RSI): | 19.29 | Sell |
Chaikin Money Flow: | -1541403 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.26 | Sell |
20-day SMA: | 13.56 | Sell |
50-day SMA: | 12.96 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.23 | Sell |
20-day EMA: | 13.3 | Sell |
50-day EMA: | 13.74 | Sell |
200-day EMA: | 11.34 | Buy |
SNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.96 | Sell |
20-day SMA: | 127.26 | Sell |
50-day SMA: | 135.63 | Sell |
200-day SMA: | 123.08 | Sell |
8-day EMA: | 119.31 | Sell |
20-day EMA: | 126.2 | Sell |
50-day EMA: | 130.12 | Sell |
200-day EMA: | 123.86 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
TD Synnex Earnings Growth & SNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.07 per share, an increase this year of $0.55 per share, and an increase next year of $1.58 per share.
Bicara Therapeutics Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
TD Synnex Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |